Skip to content

Clinical study on the therapeutic effect of intestinal flora transplantation on Alzheimer's disease

Clinical study on the therapeutic effect of intestinal flora transplantation on Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078857
Enrollment
Unknown
Registered
2023-12-20
Start date
2023-12-25
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

Study Group:Fecal Microbiota Transplantation

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients met the 2011 NIA-AA diagnostic criteria for AD, 2. Can cooperate with the colonoscopy, 3. Have self-care ability, 4. Patient and family sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Does not meet the diagnostic criteria, 2. Combined psychiatric problems, 3. Complicated with severe cardiovascular and cerebrovascular diseases, 4. Organic diseases of digestive tract, 5. Not willing to participate in this study.

Design outcomes

Primary

MeasureTime frame
CDR;

Secondary

MeasureTime frame
MMSE, MoCA, anxiety, depression, and quality of life scores;Detection of intestinal flora, microbial metabolites, AD peripheral blood core markers and periphera;Functional MRI of the brain;Any adverse reaction;

Countries

China

Contacts

Public ContactXiping Ding

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

dingxipingyx@163.com+86 189 6378 1399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026